Giuseppe Visani Selected Research

Giuseppe Visani Research Topics

Disease

17	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 06/2002
13	Neoplasms (Cancer) 01/2021 - 09/2002
10	Multiple Myeloma 12/2012 - 04/2005
9	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021 - 12/2010
8	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 09/2003
7	Leukemia 01/2021 - 09/2002
7	Lymphoma (Lymphomas) 01/2021 - 09/2003
7	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2016 - 09/2004
6	Hodgkin Disease (Hodgkin's Disease) 01/2019 - 01/2009
4	Infections 05/2011 - 07/2002
3	Thrombocytopenia (Thrombopenia) 06/2015 - 12/2002
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2011 - 04/2004
3	Primary Myelofibrosis (Myelosclerosis) 05/2010 - 12/2002
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 08/2004 - 03/2002
3	Acute Promyelocytic Leukemia 01/2004 - 06/2002
2	Residual Neoplasm 01/2021 - 08/2014
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019 - 01/2012
2	Iron Overload 01/2018 - 07/2002
2	Thalassemia 02/2015 - 07/2002
2	beta-Thalassemia (Cooley's Anemia) 12/2007 - 07/2002
2	Anemia 10/2005 - 12/2002
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2021
1	COVID-19 01/2021
1	Inflammation (Inflammations) 01/2021
1	Hairy Cell Leukemia 01/2021
1	Disease Progression 10/2020
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2019
1	Fatigue 01/2018
1	Breast Neoplasms (Breast Cancer) 11/2016
1	Second Primary Neoplasms (Neoplasms, Second) 11/2016
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2016
1	Lung Diseases (Lung Disease) 06/2013
1	Pleural Effusion (Pleural Effusions) 06/2013
1	Polycythemia Vera 01/2013
1	Pneumonia (Pneumonitis) 05/2011
1	Pericardial Effusion 04/2011
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2011

Drug/Important Bio-Agent (IBA)

9	Thalidomide (Thalomid)FDA Link 05/2011 - 03/2002
8	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2020 - 06/2004
8	Imatinib Mesylate (Gleevec)FDA Link 10/2017 - 08/2004
7	liposomal doxorubicin (Doxil)FDA Link 01/2011 - 01/2006
5	nilotinib FDA Link 01/2021 - 03/2013
5	Tyrosine Kinase InhibitorsIBA 01/2021 - 03/2013
5	Dexamethasone (Maxidex)FDA LinkGeneric 08/2010 - 01/2006
4	IronIBA 01/2021 - 07/2002
4	Etoposide (VP 16)FDA LinkGeneric 11/2014 - 10/2005
4	Dasatinib (BMS 354825)FDA Link 06/2013 - 12/2010
3	Rituximab (Mabthera)FDA Link 01/2021 - 04/2010
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2007
3	AnthracyclinesIBA 01/2019 - 10/2008
3	Melphalan (Alkeran)FDA LinkGeneric 11/2014 - 08/2010
3	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2011 - 06/2008
3	fludarabineIBA 11/2008 - 09/2004
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2004 - 06/2002
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2019
2	Core Binding Factors (Core-Binding Factor)IBA 06/2015 - 07/2004
2	Bendamustine Hydrochloride FDA Link 11/2014 - 09/2011
2	Pharmaceutical PreparationsIBA 10/2014 - 03/2009
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2011 - 09/2004
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 11/2008 - 09/2004
2	Alemtuzumab (Campath)FDA Link 12/2006 - 04/2004
2	Hemoglobins (Hemoglobin)IBA 10/2005 - 12/2002
2	Gemtuzumab (Mylotarg)FDA Link 09/2004 - 06/2004
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2003 - 08/2003
1	VemurafenibIBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	VaccinesIBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	tosedostatIBA 10/2020
1	SteroidsIBA 01/2019
1	CalreticulinIBA 01/2019
1	Adenosine Triphosphate (ATP)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Transferrin (beta 2 Transferrin)IBA 01/2018
1	Lenalidomide (CC 5013)FDA Link 11/2017
1	Complement System Proteins (Complement)IBA 01/2017
1	Carmustine (FIVB)FDA Link 08/2015
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 06/2015
1	HomoharringtonineIBA 01/2014
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2013
1	Indicators and Reagents (Reagents)IBA 01/2013
1	Immunoglobulins (Immunoglobulin)IBA 01/2012
1	Drug CombinationsIBA 05/2011
1	Surface Antigens (Surface Antigen)IBA 02/2011
1	Prednisolone (Predate)FDA LinkGeneric 01/2011
1	Vincristine (Oncovin)FDA LinkGeneric 01/2011
1	Prednisone (Sone)FDA LinkGeneric 08/2010

Therapy/Procedure

24	Therapeutics 01/2021 - 12/2002
17	Stem Cell Transplantation 01/2019 - 12/2002
14	Drug Therapy (Chemotherapy) 01/2019 - 09/2002
5	Transplantation 08/2015 - 09/2003
3	Immunotherapy 01/2021 - 02/2011
3	Radiotherapy 11/2016 - 09/2002
2	Hematopoietic Stem Cell Transplantation 01/2019 - 10/2008
1	Adjuvant Chemotherapy 11/2016
1	Consolidation Chemotherapy 08/2014
1	Antibiotic Prophylaxis 05/2011